Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Background: Pregnancy malaria is caused by Plasmodium falciparum-infected erythrocytes binding the placental receptor chondroitin sulfate A (CSA). This results in accumulation of parasites in the placenta with severe clinical consequences for the mother and her unborn child. Women become resistant to placental malaria as antibodies are acquired which specifically target the surface of infected erythrocytes binding in the placenta. VAR2CSA is most likely the parasite-encoded protein which mediates binding to the placental receptor CSA. Several domains have been shown to bind CSA in vitro; and it is apparent that a VAR2CSA-based vaccine cannot accommodate all the CSA binding domains and serovariants. It is thus of high priority to define minimal ligand binding regions throughout the VAR2CSA molecule. Methods: To define minimal CSA-binding regions/peptides of VAR2CSA, a phage display library based on the entire var2csa coding region was constructed. This library was screened on immobilized CSA and cells expressing CSA resulting in a limited number of CSA-binding phages. Antibodies against these peptides were affinity purified and tested for reactivity against CSA-binding infected erythrocytes. Results: The most frequently identified phages expressed peptides residing in the parts of VAR2CSA previously defined as CSA binding. In addition, most of the binding regions mapped to surface-exposed parts of VAR2CSA. The binding of a DBL2X peptide to CSA was confirmed with a synthetic peptide. Antibodies against a CSA-binding DBL2X peptide reacted with the surface of infected erythrocytes indicating that this epitope is accessible for antibodies on native VAR2CSA on infected erythrocytes. Conclusion: Short continuous regions of VAR2CSA with affinity for multiple types of CSA were defined. A number of these regions localize to CSA-binding domains and to surface-exposed regions within these domains and a synthetic peptide corresponding to a peptide sequence in DBL2 was shown to bind to CSA and not to CSC. It is likely that some of these epitopes are involved in native parasite CSA adhesion. However, antibodies directed against single epitopes did not inhibit parasite adhesion. This study supports phage display as a technique to identify CSA-binding regions of large proteins such as VAR2CSA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407 · cited 1×
“The best characterized surface protein is the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) [5,6], which is encoded by the polymorphic var gene family containing 50–60 copies per parasite genome [7].”
BackgroundSu, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 2×
“In the placenta IE exclusively bind to the glycosaminoglycan CSA [19,20].”
BackgroundSmith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005 · cited 1×
“The best characterized surface protein is the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) [5,6], which is encoded by the polymorphic var gene family containing 50–60 copies per parasite genome [7].”
BackgroundAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 1×
“The parasite protein mediating IE adhesion to CSA in the placenta is a distinct member of the PfEMP1 protein family, named VAR2CSA [21].”
BackgroundSelf-citationIntercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum
Berendt, A. R., Simmons, D. L., Tansey, J., Newbold, C. I., & Marsh, K. (1989) · Nature · doi:10.1038/341057a0 · Cited by 689 · cited 1×
“Several molecules such as ICAM-1 [14], VCAM-1 [15], thrombospondin [16], CD36 [17], and chondroitin sulfate A (CSA) [18,19] have been identified as host receptors for PfEMP1.”
BackgroundMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659 · cited 1×
“Women who have acquired immunity against malaria during childhood become susceptible to malaria during pregnancy due to novel parasite phenotypes expressing unique antigens not encountered during childhood infections [2,3].”
BackgroundBull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604 · cited 1×
“High levels of anti-VAR2CSA antibodies are correlated with favourable birth outcome and they are acquired as a function of parity [ 22 ].”
BackgroundSelf-citation
Research works printed but not linked: 1
- 31. Novagen: T7Select System Manual TB178. Novagen, Madison, WI 2002.
Cited by
Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice
Zhang, B., Tan, L., Yu, Y., Wang, B., Chen, Z., Han, J., Li, M., Chen, J., Xiao, T., Ambati, B. K., et al. (2018) · Theranostics · doi:10.7150/thno.22904 · Cited by 128
“Phage screening identified a peptide from the DBL2X domain that selectively binds to CSA [17]; we named this synthetic peptide placental CSA binding peptide (plCSA-BP).”
Nielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92
“Furthermore, several domains and regions of VAR2CSA have been shown to bind CSA in vitro (11, 17).”
BackgroundSelf-citationDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
“In another approach to identify CSA binding motifs, a phage library of var2csa gene fragments was panned on CSA-expressing cells or soluble CSA, and identified CSA-binding peptides derived from the first five domains (DBL1 through DBL5) and not DBL6 [21].”
BackgroundHviid, L. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9602 · Cited by 75
Zhang, B., Liang, R., Zheng, M., Cai, L., & Fan, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153642 · Cited by 69
Sander, A. F., Salanti, A., Lavstsen, T., Nielsen, M. A., Magistrado, P., Lusingu, J., Ndam, N. T., & Arnot, D. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006667 · Cited by 64
“women who had suffered pregnancy associated malaria [58].”
BackgroundSelf-citationBarfod, L., Dobrilovic, T., Magistrado, P., Khunrae, P., Viwami, F., Bruun, J., Dahlbäck, M., Bernasconi, N. L., Fried, M., John, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002390 · Cited by 62
“interaction of VAR2CSA with CSA (40), although the results of single-domain constructs should be interpreted with caution (41).”
BackgroundResultSelf-citationModulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport
Lenders, V., Koutsoumpou, X., Phan, P., Soenen, S. J., Allegaert, K., Vleeschouwer, S. D., Toelen, J., Zhao, Z., & Manshian, B. B. (2023) · Chemical Society Reviews · doi:10.1039/d1cs00574j · Cited by 53
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
Zhang, B., Cheng, G., Zheng, M., Han, J., Wang, B., Li, M., Chen, J., Xiao, T., Zhang, J., Cai, L., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435750 · Cited by 49
“CSA-binding peptide (EDVKDINFDTKEKFLAGCLIVSFHEGKC) (Resende et al., 2008) and the scrambled peptide (SCR, EVDNDKKLGLVFEKD KIFTEFACISHCG) were synthesized by ChinaPeptides Co.”
InfluentialGanguly, E., Hula, N., Spaans, F., Cooke, C. M., & Davidge, S. T. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104836 · Cited by 55
Multilaboratory Approach to Preclinical Evaluation of Vaccine Immunogens for Placental Malaria
Fried, M., Avril, M., Chaturvedi, R., Fernandez, P., Lograsso, J., Narum, D., Nielsen, M. A., Oleinikov, A. V., Resende, M., Salanti, A., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01106-12 · Cited by 38
Self-citationDoritchamou, J. Y. A., Morrison, R., Renn, J. P., Ribeiro, J., Duan, J., Fried, M., & Duffy, P. E. (2019) · Communications Biology · doi:10.1038/s42003-019-0704-z · Cited by 31
Achur, R. N., Kakizaki, I., Goel, S., Kojima, K., Madhunapantula, S. V., Goyal, A., Ohta, M., Kumar, S., Takagaki, K., & Gowda, D. C. (2008) · Biochemistry · doi:10.1021/bi801643m · Cited by 31
“falciparum Var genes, recent studies demonstrated that polymorphism in the Var2-CSA PfEMP1 DBL3X, the domain that is implicated in C4S binding, confines to smaller discrete variable regions within long stretches of highly conserved regions (34-37).”
Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains?
Dahlbäck, M., Nielsen, M. A., & Salanti, A. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.02.002 · Cited by 33
Self-citationMolecular Principles of Intrauterine Growth Restriction in Plasmodium Falciparum Infection
Seitz, J., Prieto, D. M. M., Fávaro, R. R., Schneider, H., & Markert, U. R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00098 · Cited by 36
“Four domains (DBL2, DBL3, DBL5, and DBL6) which bind to CSA have been found (Table 2).”
InfluentialMitran, C. J., Mena, A., Gnidehou, S., Banman, S. L., Arango, E., Lima, B. A. S., Lugo, H., Ganesan, A., Salanti, A., Mbonye, A. K., et al. (2019) · mBio · doi:10.1128/mbio.02343-19 · Cited by 23
“(E) Homology model of DBL5 depicting P20 (orange), P23 (red), and the putative glycosaminoglycan binding site (yellow) (42).”
BackgroundSelf-citationOncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors
Khazamipour, N., Al-Nakouzi, N., Oo, H. Z., Ørum-Madsen, M. S., Steinø, A., Sorensen, P. H. B., & Daugaard, M. (2020) · Cells · doi:10.3390/cells9040818 · Cited by 21
Butterfield, K. C., Caplan, M. R., & Panitch, A. (2010) · Biochemistry · doi:10.1021/bi9021044 · Cited by 21
Gnidehou, S., Jessen, L., Gangnard, S., Ermont, C., Triqui, C., Quiviger, M., Guitard, J., Lund, O., Deloron, P., & Ndam, N. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013105 · Cited by 18
“Several of these domains, including DBL5e, have, to some extent, displayed affinity for CSA in vitro [12,13,14,15] [16].”
Self-citationProgress and new horizons toward a VAR2CSA-based placental malaria vaccine
Doritchamou, J., Suurbaar, J., & Ndam, N. T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878029 · Cited by 21
Self-citationSaveria, T., Oleinikov, A. V., Wiliamson, K., Chaturvedi, R., Lograsso, J., Keitany, G. J., Fried, M., & Duffy, P. E. (2013) · Infection and Immunity · doi:10.1128/iai.00978-12 · Cited by 15
“Variant surface antigen 2-CSA (VAR2CSA), a PfEMP1 protein, is selectively expressed in CSAbinding placental parasites (10, 11) and encodes 6 extracellular domains, of which several have been demonstrated to bind to CSA in vitro (12, 13).”
BackgroundRed Blood Cells Oligosaccharides as Targets for Plasmodium Invasion
Burzyńska, P., Jodłowska, M., Zerka, A., Czujkowski, J., & Jaśkiewicz, E. (2022) · Biomolecules · doi:10.3390/biom12111669 · Cited by 14
Pregnancy malaria: cryptic disease, apparent solution
Duffy, P. E., & Fried, M. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000900008 · Cited by 12
“Additionally, recombinant proteins containing any of several VAR2CSA domains can bind to CSA (Gamain et al. 2005, Resende et al. 2008).”
BackgroundDecoding the Role of Glycans in Malaria
Gomes, P. S., Feijó, D. F., Morrot, A., & Freire-de-Lima, C. G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01071 · Cited by 11
“…al., 2005); this leads to accumulation of Plasmodium parasites in the placenta, resulting in severe clinical consequences for both mother and child (Resende et al., 2008), such that the investigation of this interaction is a viable target for vaccines (Clausen et al., 2012; Fried and Duffy, 2017).”
BackgroundHuang, B., Wang, H., An, Z., Yang, Z., Cao, J., Wang, L., Luo, X., & Qi, H. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104103 · Cited by 4
Septic shock complicating Plasmodium falciparum malaria in a pregnant patient with low parasitemia
Boissier, F., Vermersch, C., Spagnolo, S., Bruneel, F., Brun‐Buisson, C., & de Prost, N. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.09.005 · Cited by 1
Malaria and polypeptides of Plasmodium falciparum at the infected erythrocyte surface
Palmkvist, M. (2016) · Figshare · Cited by 1
Zhao, H., Li, C., Zhu, W., Yu, M., Huang, B., Wang, X., Li, J., Yang, Y., Xue, L., Ni, J., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14131775.v1 · Cited by 1
Mitran, C. J. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-qs9p-em57
Rovira-Vallbona, E. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Horii, T., & Palacpac, N. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737042731.793573191
Zhao, H., Li, C., Zhu, W., Yu, M., Huang, B., Wang, X., Li, J., Yang, Y., Xue, L., Ni, J., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14131775
Recent Advances in Malaria Vaccine Development
Mahanta, S. K. (2022) · Wiley eBooks · doi:10.1002/9783527830589.ch13
Chondroitin sulfate-derived theranostic nanosystems
Aquib, M., Wande, D. P., Kutoka, P. T., Khamis, A. M., Farooq, M. A., Akhtar, F., Sohail, M., & Wang, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85656-0.00023-1
Mazey, E., Flannery, S., Fischer, R., Kandžija, N., Zhang, W., Yamada, Y., Tokeshi, M., Johnson, E., Akbar, N., Bancroft, J. M., et al. (2026) · Biomolecules · doi:10.3390/biom16050628
“…peptide EDVKDINFDTKEKFLAGCLIVSFHEGKC (EC), also known as the placental chondroitin sulphate A-binding peptide (plCSA-bp), binds chondroitin sulphate A on trophoblast cells and has demonstrated placental specificity in vivo, making it an attractive candidate for placenta-directed delivery [27–30].”
Metadata
- Authors
- Resende, M., Nielsen, M. A., Dahlbäck, M., Ditlev, S. B., Andersen, P., Sander, A. F., Ndam, N. T., Theander, T. G., & Salanti, A.
- Affiliations
- University of Copenhagen (DK)
- Technical University of Denmark (DK)
- Institut de Recherche pour le Développement (FR)
- Corresponding author
- Salanti, Ali
- Venue
- Malaria Journal
- Published
- 2008-06-06
- Volume
- 7
- Issue
- 1
- Pages
- 104-104
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC2430714
- OpenAlex
- W2123626092
- Cited by
- 36
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Sundhed og Sygdom, Det Frie Forskningsråd
- Fondation pour la Recherche Médicale
- Medical Research Council
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- VAR2CSA, chondroitin sulfate A, placental sequestration, Plasmodium falciparum, glycosaminoglycan binding, phage display, epitope mapping, infected erythrocyte adhesion, chondroitin sulfate C
- MeSH terms
- Animals, Antibodies, Protozoan, Antigens, Protozoan, Binding Sites, Cell Line, Chondroitin Sulfates, Humans, Plasmodium falciparum, Protein Binding, Protein Structure, Tertiary, Peptide Library
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.